pubmed-article:12792297 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12792297 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
pubmed-article:12792297 | lifeskim:mentions | umls-concept:C2292302 | lld:lifeskim |
pubmed-article:12792297 | lifeskim:mentions | umls-concept:C0029458 | lld:lifeskim |
pubmed-article:12792297 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:12792297 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
pubmed-article:12792297 | lifeskim:mentions | umls-concept:C0694643 | lld:lifeskim |
pubmed-article:12792297 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:12792297 | pubmed:dateCreated | 2003-6-6 | lld:pubmed |
pubmed-article:12792297 | pubmed:abstractText | To assess the efficacy of a continuous-combined transdermal patch (estradiol/ norethisterone acetate [E(2)/NETA] 25/125; Estragest TTS, Novartis, Basel, Switzerland) in the reduction of bone loss in postmenopausal women. | lld:pubmed |
pubmed-article:12792297 | pubmed:language | eng | lld:pubmed |
pubmed-article:12792297 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12792297 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12792297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12792297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12792297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12792297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12792297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12792297 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12792297 | pubmed:issn | 1072-3714 | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:RubinacciAles... | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:De... | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:Quebe-Fehling... | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:ModenaAlberto... | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:PeruzziElenaE | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:ZanardiEttore... | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:AndreiBrunoB | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:PansiniFrance... | lld:pubmed |
pubmed-article:12792297 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:12792297 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12792297 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:12792297 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12792297 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12792297 | pubmed:pagination | 241-9 | lld:pubmed |
pubmed-article:12792297 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:meshHeading | pubmed-meshheading:12792297... | lld:pubmed |
pubmed-article:12792297 | pubmed:articleTitle | Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. | lld:pubmed |
pubmed-article:12792297 | pubmed:affiliation | Bone Metabolic Unit, Scientific Institute, San Raffaele Hospital, Milan, Italy. rubinacci.alessandro@hsr.it | lld:pubmed |
pubmed-article:12792297 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12792297 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12792297 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:12792297 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12792297 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12792297 | lld:pubmed |